Goodwin, Davis Polk Lead Avalyn's Upsized $300M IPO
Biotechnology firm Avalyn Pharma Inc. began trading publicly Thursday after raising $300 million in an upsized initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article